Combined inhibition of ErbB1/2 and Notch receptors effectively targets breast ductal carcinoma in situ (DCIS) stem/progenitor cell activity regardless of ErbB2 status.
Pathways involved in DCIS stem and progenitor signalling are poorly understood yet are critical to understand DCIS biology and to develop new therapies. Notch and ErbB1/2 receptor signalling cross talk has been demonstrated in invasive breast cancer, but their role in DCIS stem and progenitor cells...
Guardado en:
Autores principales: | Gillian Farnie, Pamela M Willan, Robert B Clarke, Nigel J Bundred |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2013
|
Materias: | |
Acceso en línea: | https://doaj.org/article/3c976276baef469e838d2f525a5d9bbd |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Betacellulin-induced beta cell proliferation and regeneration is mediated by activation of ErbB-1 and ErbB-2 receptors.
por: Yoon Sin Oh, et al.
Publicado: (2011) -
ErbB1 and ErbB3 co-over expression as a prognostic factor in gastric cancer
por: Moghbeli,Meysam, et al.
Publicado: (2019) -
Coronary vasculature patterning requires a novel endothelial ErbB2 holoreceptor
por: Haig Aghajanian, et al.
Publicado: (2016) -
Increased NRG1-ErbB4 signaling in human symptomatic epilepsy
por: Jun-Ming Zhu, et al.
Publicado: (2017) -
Anti-tubulin drugs conjugated to anti-ErbB antibodies selectively radiosensitize
por: Stephen R. Adams, et al.
Publicado: (2016)